Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 409, 307-312 (18 January 2001) | doi:10.1038/35053000; Received 9 June 2000; Accepted 15 November 2000
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Paleobiologist / Biogeochemist
- University of Cincinnati
- Cincinnati, Ohio, USA
Instrumentation Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
The hormone resistin links obesity to diabetes
Claire M. Steppan, Shannon T. Bailey, Savitha Bhat, Elizabeth J. Brown, Ronadip R. Banerjee, Christopher M. Wright, Hiralben R. Patel, Rexford S. Ahima & Mitchell A. Lazar
- Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine and Genetics, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Correspondence to: Mitchell A. Lazar Correspondence and requests for materials should be addressed
to M.A.L.
(e-mail: Email: lazar@mail.med.upenn.edu).
The
mouse and human resistin proteins are deposited under GenBank accession numbers
AF323080 and AF323081, respectively.
Abstract
Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and insulin action. Insulin-stimulated glucose uptake by adipocytes is enhanced by neutralization of resistin and is reduced by resistin treatment. Resistin is thus a hormone that potentially links obesity to diabetes.
- Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine and Genetics, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Correspondence to: Mitchell A. Lazar Correspondence and requests for materials should be addressed
to M.A.L.
(e-mail: Email: lazar@mail.med.upenn.edu).
The
mouse and human resistin proteins are deposited under GenBank accession numbers
AF323080 and AF323081, respectively.
To read this story in full you will need to login or make a payment (see right).

